Singal AG, Nagar SP, Hitchens A, Davis KL, Iyer S. Real-world effectiveness of Lenvatinib monotherapy in previously treated unresectable hepatocellular carcinoma in US clinical practice. Cancer Rep (Hoboken). 2023 Jan;6(1):e1679. doi: 10.1002/cnr2.1679
Musetti SN, Huang L. Tinagl1 gene therapy suppresses growth and remodels the microenvironment of triple negative breast cancer. Mol Pharm. 2021 May 3;18(5):2032-8. doi: 10.1021/acs.molpharmaceut.1c00008
Chung AH, Leisner TM, Dardis GJ, Bivins MM, Keller AL, Parise LV. CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death. Cancer Cell Int. 2019 Feb 4;19(26). doi: 10.1186/s12935-019-0740-2